retatrutide approval status 2025 fda ema Side Effects Guide: 21 Proven Remedies That Work Outlook for Obesity in 2026:

Shiloach J, Fass R

Retatrutide's glucagon component introduces an additional monitoring consideration: transient increases in fasting plasma glucose have been observed, particularly during dose escalation at 12 mg

What meal timing and portion strategies help manage GLP-1 side effects

However, because it is newer, clinicians review individual suitability carefully and monitor side effects closely

And Wegovy , the version of semaglutide that is approved for weight loss, might be a better option overall

Together, these modifications reduce IGFBP binding affinity by approximately 100-fold while preserving full agonist activity at the type 1 IGF receptor (IGF-1R), creating a molecule with dramatically enhanced bioavailability in biological systems